World news, news around town, tech update 3
Ad
Wednesday, 4 December 2019
AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment
AstraZeneca Plc and Merck & Co Inc said on Thursday that their drug, Lynparza, won approval in China as a first line treatment for a from of ovarian cancer.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment